Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$66.00 – $70.63
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.62B | $12.41B | $10.71B | $15.90B | $17.97B | $14.38B | $14.18B | $12.94B |
| Cost of revenue | $9.92B | $9.66B | $8.21B | $11.47B | $15.40B | $12.07B | $12.00B | $11.22B |
| Gross profit | $4.70B | $2.75B | $2.50B | $4.43B | $2.56B | $2.31B | $2.18B | $1.72B |
| Gross margin | 32.1% | 22.2% | 23.3% | 27.8% | 14.3% | 16.0% | 15.4% | 13.3% |
| R&D | $276.0M | $266.0M | $262.0M | $341.0M | $361.0M | $374.0M | $392.0M | $341.9M |
| Operating income | $2.58B | $852.0M | $710.0M | $2.25B | $306.0M | $156.0M | $27.0M | −$434.8M |
| EBITDA | $3.16B | $1.60B | $1.48B | $3.10B | $1.65B | $1.14B | $1.12B | $425.8M |
| Net income | $1.82B | $552.0M | $459.0M | $1.62B | −$272.0M | −$198.0M | −$266.0M | −$643.8M |
| Net margin | 12.5% | 4.4% | 4.3% | 10.2% | -1.5% | -1.4% | -1.9% | -5.0% |
| EPS (diluted) | 9.46 | 3.02 | 2.48 | 8.37 | -1.42 | -1.05 | -1.41 | -3.39 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $12.5B | $0.29 | $0.27–$0.30 | 1 |
| 2027 | $12.8B | $0.76 | $0.72–$0.80 | 1 |
| 2028 | $13.9B | $0.20 | $0.19–$0.21 | 1 |
| 2029 | $14.3B | $0.70 | $0.66–$0.73 | 1 |
Forward consensus · source: Financial Modeling Prep
COVESTRO AG ORD
No one on the platform currently holds CVVTF.
No tracked institution reports a position in CVVTF as of their last filing.
No one on the platform has traded CVVTF yet.
| $34.8B |
| — |
| ALBAlbemarle Corporation | $135.03 | +4.09% | $15.9B | — |
| APDAir Products and Chemicals, Inc. | $293.18 | +8.04% | $65.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.9× sales vs its 0.7× historical median P/S.
Fair value ≈ $51.21 · price $70.63 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.